Analyst Ratings for Spero Therapeutics (SPRO)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.4 / 10
Percentile Rank: 45%
Rating Score: 4.4 / 10
Percentile Rank: 45%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/20/2024 | Evercore ISI | Josh Schimmer | Downgrade | In Line (Outperform) |
5.00 (N/A) |
0.99 (2.30) |
132.32% | Details |
| 11/18/2024 | TD Cowen | Ritu Baral | Downgrade | Hold (Buy) |
N/A (N/A) |
1.25 (2.30) |
84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
